Andreas Herrlich

1.7k total citations
30 papers, 1.3k citations indexed

About

Andreas Herrlich is a scholar working on Molecular Biology, Oncology and Nephrology. According to data from OpenAlex, Andreas Herrlich has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Nephrology. Recurrent topics in Andreas Herrlich's work include HER2/EGFR in Cancer Research (7 papers), Cell Adhesion Molecules Research (7 papers) and Acute Kidney Injury Research (6 papers). Andreas Herrlich is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Cell Adhesion Molecules Research (7 papers) and Acute Kidney Injury Research (6 papers). Andreas Herrlich collaborates with scholars based in United States, Germany and Israel. Andreas Herrlich's co-authors include Thomas Gudermann, Günter Schultz, Robert Grosse, Monika Hartmann, Peter Herrlich, Andrea Schmid, Eirini Kefaloyianni, Bernhard Kühn, Peter Herrlich and Henrik Daub and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Andreas Herrlich

29 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Herrlich United States 20 693 267 166 141 141 30 1.3k
Xiang‐Xi Xu United States 26 1.2k 1.8× 200 0.7× 216 1.3× 73 0.5× 155 1.1× 42 1.7k
Heather S. Bevan United Kingdom 12 796 1.1× 226 0.8× 62 0.4× 62 0.4× 78 0.6× 12 1.1k
Camila Avivi Israel 24 650 0.9× 494 1.9× 78 0.5× 118 0.8× 538 3.8× 53 1.7k
Douglas W. Burton United States 23 810 1.2× 563 2.1× 46 0.3× 61 0.4× 69 0.5× 52 1.6k
Angela Russo United States 20 537 0.8× 142 0.5× 119 0.7× 24 0.2× 106 0.8× 38 1.0k
Michael Leserer Germany 4 1.2k 1.7× 576 2.2× 71 0.4× 28 0.2× 176 1.2× 4 1.9k
Laura A. Maile United States 28 874 1.3× 120 0.4× 52 0.3× 62 0.4× 317 2.2× 48 1.5k
Noël Lamandé France 21 865 1.2× 124 0.5× 60 0.4× 37 0.3× 133 0.9× 38 1.6k
Sybille Esser Germany 8 1.1k 1.6× 148 0.6× 25 0.2× 60 0.4× 177 1.3× 9 1.6k
Francesca L. Sciacca Italy 21 549 0.8× 513 1.9× 34 0.2× 30 0.2× 445 3.2× 48 1.7k

Countries citing papers authored by Andreas Herrlich

Since Specialization
Citations

This map shows the geographic impact of Andreas Herrlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Herrlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Herrlich more than expected).

Fields of papers citing papers by Andreas Herrlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Herrlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Herrlich. The network helps show where Andreas Herrlich may publish in the future.

Co-authorship network of co-authors of Andreas Herrlich

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Herrlich. A scholar is included among the top collaborators of Andreas Herrlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Herrlich. Andreas Herrlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Komaru, Yohei, Eirini Kefaloyianni, Mark J. Miller, et al.. (2025). Acute kidney injury triggers hypoxemia by lung intravascular neutrophil retention that reduces capillary blood flow. Journal of Clinical Investigation. 135(10). 3 indexed citations
2.
Ojha, Rupal, et al.. (2025). Neuroinflammation and Neurological Dysfunction After AKI Is Driven by Kidney-Released Osteopontin and Not Uremia. Journal of the American Society of Nephrology. 36(10S).
3.
Jiménez, Jesús, Junedh Amrute, Pan Ma, et al.. (2025). The immune checkpoint regulator CD40 potentiates myocardial inflammation. Nature Cardiovascular Research. 4(4). 458–472. 2 indexed citations
4.
Schmidt, Insa M., Ashish Verma, Venkata Sabbisetti, et al.. (2024). Associations of Serum Amphiregulin Levels With Kidney Failure and Mortality: The Chronic Renal Insufficiency Cohort (CRIC). Kidney Medicine. 7(3). 100958–100958. 1 indexed citations
5.
6.
Kefaloyianni, Eirini, Hao Dun, Amy C. Keller, et al.. (2022). Identification of kidney injury–released circulating osteopontin as causal agent of respiratory failure. Science Advances. 8(8). 53 indexed citations
7.
Chang-Panesso, Monica, Farid F. Kadyrov, Matthew A. Lalli, et al.. (2019). FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury. Journal of Clinical Investigation. 129(12). 5501–5517. 115 indexed citations
8.
Wilson, Jennifer L., Eirini Kefaloyianni, Lauren Stopfer, et al.. (2017). Functional Genomics Approach Identifies Novel Signaling Regulators of TGFα Ectodomain Shedding. Molecular Cancer Research. 16(1). 147–161. 2 indexed citations
9.
Herrlich, Peter & Andreas Herrlich. (2017). ADAM Metalloprotease-Released Cancer Biomarkers. Trends in cancer. 3(7). 482–490. 20 indexed citations
10.
Hartmann, Monika, et al.. (2016). Growth factor and co-receptor release by structural regulation of substrate metalloprotease accessibility. Scientific Reports. 6(1). 37464–37464. 4 indexed citations
11.
Kefaloyianni, Eirini, Jakob Kaeppler, Xiaoming Sun, et al.. (2016). ADAM17 substrate release in proximal tubule drives kidney fibrosis. JCI Insight. 1(13). 104 indexed citations
12.
Hartmann, Monika, et al.. (2015). Tumor Suppressor NF2 Blocks Cellular Migration by Inhibiting Ectodomain Cleavage of CD44. Molecular Cancer Research. 13(5). 879–890. 33 indexed citations
13.
Hartmann, Monika, et al.. (2015). Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 (CD44) and of Neuregulin-1 Requires Substrate Dimerization. Journal of Biological Chemistry. 290(28). 17041–17054. 38 indexed citations
14.
Hartmann, Monika, Andreas Herrlich, & Peter Herrlich. (2013). Who decides when to cleave an ectodomain?. Trends in Biochemical Sciences. 38(3). 111–120. 57 indexed citations
16.
Miller, Miles A., Layla J. Barkal, Andreas Herrlich, et al.. (2010). Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities. Integrative Biology. 3(4). 422–438. 71 indexed citations
17.
Herrlich, Andreas, et al.. (2004). Role of proneuregulin 1 cleavage and human epidermal growth factor receptor activation in hypertonic aquaporin induction. Proceedings of the National Academy of Sciences. 101(44). 15799–15804. 20 indexed citations
18.
Grosse, Robert, et al.. (2000). Epidermal Growth Factor Receptor Tyrosine Kinase Mediates Ras Activation by Gonadotropin-releasing Hormone. Journal of Biological Chemistry. 275(16). 12251–12260. 58 indexed citations
19.
Grosse, Robert, Andrea Schmid, Torsten Schöneberg, et al.. (2000). Gonadotropin-releasing Hormone Receptor Initiates Multiple Signaling Pathways by Exclusively Coupling to Gq/11Proteins. Journal of Biological Chemistry. 275(13). 9193–9200. 123 indexed citations
20.
Herrlich, Andreas, Bernhard Kühn, Robert Grosse, et al.. (1996). Involvement of Gs and Gi Proteins in Dual Coupling of the Luteinizing Hormone Receptor to Adenylyl Cyclase and Phospholipase C. Journal of Biological Chemistry. 271(28). 16764–16772. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026